40T — ISEC Healthcare Income Statement
0.000.00%
- SG$189.98m
- SG$197.37m
- SG$79.21m
Annual income statement for ISEC Healthcare, fiscal year end - December 31st, SGD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 40.5 | 63 | 70 | 74.2 | 79.2 |
| Cost of Revenue | |||||
| Gross Profit | 17.9 | 28.8 | 31 | 32.7 | 33.4 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 31 | 45.6 | 52 | 56.4 | 60.9 |
| Operating Profit | 9.5 | 17.3 | 18 | 17.8 | 18.3 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 9.09 | 16.8 | 17.3 | 17.2 | 17.7 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 6.88 | 12.7 | 13.2 | 12.9 | 13.4 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 6.91 | 12.5 | 13 | 12.8 | 13.4 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | 6.91 | 12.5 | 13 | 12.8 | 13.4 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.012 | 0.022 | 0.023 | 0.024 | 0.023 |
| Dividends per Share |